Literature DB >> 27277698

The role of α1-adrenergic receptors in regulating metabolism: increased glucose tolerance, leptin secretion and lipid oxidation.

Ting Shi1, Robert S Papay1, Dianne M Perez1.   

Abstract

The role of α1-adrenergic receptors (α1-ARs) and their subtypes in metabolism is not well known. Most previous studies were performed before the advent of transgenic mouse models and utilized transformed cell lines and poorly selective antagonists. We have now studied the metabolic regulation of the α1A- and α1B-AR subtypes in vivo using knock-out (KO) and transgenic mice that express a constitutively active mutant (CAM) form of the receptor, assessing subtype-selective functions. CAM mice increased glucose tolerance while KO mice display impaired glucose tolerance. CAM mice increased while KO decreased glucose uptake into white fat tissue and skeletal muscle with the CAM α1A-AR showing selective glucose uptake into the heart. Using indirect calorimetry, both CAM mice demonstrated increased whole body fatty acid oxidation, while KO mice preferentially oxidized carbohydrate. CAM α1A-AR mice displayed significantly decreased fasting plasma triglycerides and glucose levels while α1A-AR KO displayed increased levels of triglycerides and glucose. Both CAM mice displayed increased plasma levels of leptin while KO mice decreased leptin levels. Most metabolic effects were more efficacious with the α1A-AR subtype. Our results suggest that stimulation of α1-ARs results in a favorable metabolic profile of increased glucose tolerance, cardiac glucose uptake, leptin secretion and increased whole body lipid metabolism that may contribute to its previously recognized cardioprotective and neuroprotective benefits.

Entities:  

Keywords:  Adrenergic receptor; fatty acid oxidation; leptin; metabolism

Mesh:

Substances:

Year:  2016        PMID: 27277698      PMCID: PMC7788357          DOI: 10.1080/10799893.2016.1193522

Source DB:  PubMed          Journal:  J Recept Signal Transduct Res        ISSN: 1079-9893            Impact factor:   2.092


  70 in total

1.  Hypotension, autonomic failure, and cardiac hypertrophy in transgenic mice overexpressing the alpha 1B-adrenergic receptor.

Authors:  M J Zuscik; D Chalothorn; D Hellard; C Deighan; A McGee; C J Daly; D J Waugh; S A Ross; R J Gaivin; A J Morehead; J D Thomas; E F Plow; J C McGrath; M T Piascik; D M Perez
Journal:  J Biol Chem       Date:  2001-02-01       Impact factor: 5.157

2.  Quantification of functional selectivity at the human α(1A)-adrenoceptor.

Authors:  Bronwyn A Evans; Natalie Broxton; Jon Merlin; Masaaki Sato; Dana S Hutchinson; Arthur Christopoulos; Roger J Summers
Journal:  Mol Pharmacol       Date:  2010-10-26       Impact factor: 4.436

3.  Lipolytic effect of in vivo leptin administration on adipocytes of lean and ob/ob mice, but not db/db mice.

Authors:  G Frühbeck; M Aguado; J Gómez-Ambrosi; J A Martínez
Journal:  Biochem Biophys Res Commun       Date:  1998-09-08       Impact factor: 3.575

Review 4.  Glucose for the heart.

Authors:  C Depre; J L Vanoverschelde; H Taegtmeyer
Journal:  Circulation       Date:  1999-02-02       Impact factor: 29.690

5.  Mechanism of adrenergic stimulation of hepatic ketogenesis.

Authors:  K Kosugi; Y Harano; T Nakano; M Suzuki; A Kashiwagi; Y Shigeta
Journal:  Metabolism       Date:  1983-11       Impact factor: 8.694

6.  Alpha-adrenergic suppression of very-low-density-lipoprotein triacylglycerol secretion by isolated rat hepatocytes.

Authors:  N P Brindle; J A Ontko
Journal:  Biochem J       Date:  1988-03-01       Impact factor: 3.857

Review 7.  Adrenergic regulation of adipocyte metabolism.

Authors:  M Lafontan; P Barbe; J Galitzky; G Tavernier; D Langin; C Carpéné; A Bousquet-Melou; M Berlan
Journal:  Hum Reprod       Date:  1997-10       Impact factor: 6.918

Review 8.  Cardiac and neuroprotection regulated by α(1)-adrenergic receptor subtypes.

Authors:  Dianne M Perez; Van A Doze
Journal:  J Recept Signal Transduct Res       Date:  2011-02-21       Impact factor: 2.092

9.  Glucose transport and phosphorylation in single cardiac myocytes: rate-limiting steps in glucose metabolism.

Authors:  J Manchester; X Kong; J Nerbonne; O H Lowry; J C Lawrence
Journal:  Am J Physiol       Date:  1994-03

10.  The alpha(1A/C)- and alpha(1B)-adrenergic receptors are required for physiological cardiac hypertrophy in the double-knockout mouse.

Authors:  Timothy D O'Connell; Shinji Ishizaka; Akihiro Nakamura; Philip M Swigart; M C Rodrigo; Gregory L Simpson; Susanna Cotecchia; D Gregg Rokosh; William Grossman; Elyse Foster; Paul C Simpson
Journal:  J Clin Invest       Date:  2003-06       Impact factor: 14.808

View more
  7 in total

Review 1.  ASAS-SSR Triennnial Reproduction Symposium: Looking Back and Moving Forward-How Reproductive Physiology has Evolved: Fetal origins of impaired muscle growth and metabolic dysfunction: Lessons from the heat-stressed pregnant ewe.

Authors:  Dustin T Yates; Jessica L Petersen; Ty B Schmidt; Caitlin N Cadaret; Taylor L Barnes; Robert J Posont; Kristin A Beede
Journal:  J Anim Sci       Date:  2018-06-29       Impact factor: 3.159

2.  Acute exposure of primary rat soleus muscle to zilpaterol HCl (β2 adrenergic agonist), TNFα, or IL-6 in culture increases glucose oxidation rates independent of the impact on insulin signaling or glucose uptake.

Authors:  Caitlin N Cadaret; Kristin A Beede; Hannah E Riley; Dustin T Yates
Journal:  Cytokine       Date:  2017-04-05       Impact factor: 3.861

Review 3.  Beyond the Calorie Paradigm: Taking into Account in Practice the Balance of Fat and Carbohydrate Oxidation during Exercise?

Authors:  Jean-Frédéric Brun; Justine Myzia; Emmanuelle Varlet-Marie; Eric Raynaud de Mauverger; Jacques Mercier
Journal:  Nutrients       Date:  2022-04-12       Impact factor: 6.706

4.  α1-Adrenergic receptors increase glucose oxidation under normal and ischemic conditions in adult mouse cardiomyocytes.

Authors:  Robert S Papay; Dianne M Perez
Journal:  J Recept Signal Transduct Res       Date:  2020-08-05       Impact factor: 2.092

Review 5.  Glucose Intolerance on Phaeochromocytoma and Paraganglioma-The Current Understanding and Clinical Perspectives.

Authors:  Ichiro Abe; Farhadul Islam; Alfred King-Yin Lam
Journal:  Front Endocrinol (Lausanne)       Date:  2020-11-26       Impact factor: 5.555

Review 6.  Targeting Adrenergic Receptors in Metabolic Therapies for Heart Failure.

Authors:  Dianne M Perez
Journal:  Int J Mol Sci       Date:  2021-05-28       Impact factor: 5.923

7.  Transglutaminase 2 Has Metabolic and Vascular Regulatory Functions Revealed by In Vivo Activation of Alpha1-Adrenergic Receptor.

Authors:  Kinga Lénárt; Attila Pap; Róbert Pórszász; Anna V Oláh; László Fésüs; András Mádi
Journal:  Int J Mol Sci       Date:  2020-05-29       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.